A treatment for a rare cancer-like lung disease found in women of childbearing age may have been discovered by University of Cincinnati researchers.
Jun 15, 2023
0
41
Women who have high blood pressure before they become pregnant may be twice as likely as those who don't to develop cardiovascular disease within a decade of giving birth, new research finds.
May 12, 2023
0
2
With a vaccine on the horizon for RSV, respiratory syncytial virus, that is designed to protect pregnant people and their fetuses, new survey research finds that women of childbearing age are more doubtful than other adults ...
Apr 11, 2023
0
12
A patchwork of state laws in the aftermath of a Supreme Court decision overturning the right to an abortion, combined with pandemic-related burnout and low reimbursement rates, could exacerbate an already looming national ...
Mar 16, 2023
0
3
The United States is still among one of the most dangerous developed nations for childbirth, especially in rural areas and communities of color, according to a new March of Dimes report. About 36 percent of U.S. counties ...
Oct 12, 2022
0
3
Women with polycystic ovary syndrome (PCOS) in Alabama may be more likely to have excessive hair growth and insulin resistance, whereas women with PCOS in California may be more likely to have higher testosterone levels, ...
Oct 11, 2022
0
3
A 10-year emulation trial of pregnant persons with inflammatory bowel disease (IBD) has found that continuation of anti–tumor necrosis factor (anti-TNF) treatment after 24 weeks of pregnancy appears beneficial regarding ...
Sep 27, 2022
0
0
Spondyloarthritis (SpA) is one of the most common chronic inflammatory diseases and regularly affects women of childbearing age. Sabrina Hamroun presents new information at EULAR about the factors associated with time-to-conception ...
Jun 3, 2022
0
1
In response to a recent column where I mentioned how genetic research is beginning to show us how our DNA may influence our dietary needs, reader Ann F sent me a slew of questions:
May 27, 2022
0
2
For the second time in as many days, the Food and Drug Administration (FDA) has granted emergency use authorization for an investigational antiviral pill to treat COVID-19. This time it is Merck's molnupiravir.
Dec 30, 2021
0
7
